These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12401355)

  • 21. Rapid and sensitive liquid chromatography-mass spectrometry method for determination of ropinirole in human plasma.
    Bhatt J; Jangid A; Shetty R; Shah B; Kambli S; Subbaiah G; Singh S
    J Pharm Biomed Anal; 2006 Mar; 40(5):1202-8. PubMed ID: 16289706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography-mass spectrometry.
    Leis HJ; Windischhofer W; Fauler G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):353-57. PubMed ID: 12361750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection.
    Lai CT; Gordon ES; Kennedy SH; Bateson AN; Coutts RT; Baker GB
    J Chromatogr B Biomed Sci Appl; 2000 Dec; 749(2):275-9. PubMed ID: 11145064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma.
    Tessier E; Neirinck L; Zhu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):295-302. PubMed ID: 14643509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of paroxetine in human plasma by high-performance liquid chromatography using 7,7,8,8-tetracyanoquinodimethane as the derivatization reagent.
    Onal A; Oztunç A
    Ther Drug Monit; 2006 Apr; 28(2):180-4. PubMed ID: 16628128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High performance liquid chromatographic method for the determination of sumatriptan with fluorescence detection in human plasma.
    Ge Z; Tessier E; Neirinck L; Zhu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):299-303. PubMed ID: 15171943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes.
    Molander P; Thomassen A; Kristoffersen L; Greibrokk T; Lundanes E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):77-87. PubMed ID: 11820298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of sertraline in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry and method validation.
    He L; Feng F; Wu J
    J Chromatogr Sci; 2005; 43(10):532-5. PubMed ID: 16438795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous monitoring of selective serotonin reuptake inhibitors in human urine, plasma and oral fluid by reverse-phase high performance liquid chromatography.
    Das R; Agrawal YK
    J Chromatogr Sci; 2013 Feb; 51(2):146-54. PubMed ID: 22914569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective and rapid liquid chromatography-mass spectrometry method for the determination of lercanidipine in human plasma.
    Salem II; Idrees J; Al Tamimi JI; Farina P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):201-7. PubMed ID: 15063326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma.
    Verhaeghe T; Diels L; de Vries R; De Meulder M; de Jong J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(2):337-46. PubMed ID: 12742124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of mianserin in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-ESI/MS): application to a bioequivalence study in Chinese volunteers.
    Xu P; Li HD; Chen BM; Ma N; Yan M; Zhu YG
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):994-9. PubMed ID: 18514457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of high-performance liquid chromatographic-mass spectrometric method for the analysis of lidocaine in human plasma.
    Chik Z; Lee TD; Holt DW; Johnston A; Tucker AT
    J Chromatogr Sci; 2006; 44(5):262-5. PubMed ID: 16774711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
    Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography.
    Lacassie E; Gaulier JM; Marquet P; Rabatel JF; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):229-38. PubMed ID: 10901127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive and specific liquid chromatographic-tandem mass spectrometric assay for barnidipine in human plasma.
    Pawula M; Watson D; Teramura T; Watanabe T; Higuchi S; Cheng KN
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):113-23. PubMed ID: 9869371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of Olanzapine and Fluoxetine in human plasma by LC-MS/MS: its pharmacokinetic application.
    Bonde SL; Bhadane RP; Gaikwad A; Gavali SR; Katale DU; Narendiran AS
    J Pharm Biomed Anal; 2014 Mar; 90():64-71. PubMed ID: 24334191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatography-mass spectrometry method for determination of anagrelide in human plasma.
    Zhu Z; Gonthier R; Neirinck L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):238-43. PubMed ID: 16005692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard.
    Li C; Ji Z; Nan F; Shao Q; Liu P; Dai J; Zhen J; Yuan H; Xu F; Cui J; Huang B; Zhang M; Yu C
    Rapid Commun Mass Spectrom; 2002; 16(19):1844-50. PubMed ID: 12271449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies.
    Segura M; Ortuño J; Farré M; Pacifici R; Pichini S; Joglar J; Segura J; de la Torre R
    Rapid Commun Mass Spectrom; 2003; 17(13):1455-61. PubMed ID: 12820211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.